Cargando…

Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen Exposure

PURPOSE: To assess the prophylactic and treatment activity of reproxalap, a novel reactive aldehyde species inhibitor, in a real-world model of allergen exposure. METHODS: In a randomized, double-masked, vehicle-controlled, crossover Phase 2 trial, 70 adult patients with ≥2 years of moderate to seve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, David, Karpecki, Paul, Salapatek, Anne Marie, Sheppard, John D, Brady, Todd C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742616/ https://www.ncbi.nlm.nih.gov/pubmed/35018093 http://dx.doi.org/10.2147/OPTH.S345324

Ejemplares similares

Birch allergen challenges in allergic conjunctivitis using standard conjunctival allergen challenge and environmental exposure chamber
por: Gherasim, Alina, et al.
Publicado: (2021)

55 Ocular Signs and Symptoms Elicited by a Naturalistic Allergen Challenge in an Environmental Exposure Chamber Model Versus a Direct Allergen Instillation Model
por: Tort, Maria J., et al.
Publicado: (2012)

Reproxalap Activity and Estimation of Clinically Relevant Thresholds for Ocular Itching and Redness in a Randomized Allergic Conjunctivitis Field Trial
por: Cavanagh, Bill, et al.
Publicado: (2022)

A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease
por: McMullin, David, et al.
Publicado: (2021)

Allergic conjunctivitis and the most common allergens in Northern Greece
por: Almaliotis, Diamantis, et al.
Publicado: (2013)

Topical cyclosporine versus allergen specific immunotherapy in perennial allergic conjunctivitis
por: Dogan, Ceylan Uslu, et al.
Publicado: (2022)

Efficacy of Allergen Immunotherapy for Allergic Asthma in Real World Practice
por: Rhyou, Hyo-In, et al.
Publicado: (2019)

Barrier‐forming, drug‐free nasal spray reduces allergic symptoms induced by house dust mite allergen
por: Couroux, Patricia, et al.
Publicado: (2023)

Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis
por: Sacchetti, Marta, et al.
Publicado: (2011)

A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease
por: Clark, David, et al.
Publicado: (2021)

Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
por: Pfaar, O., et al.
Publicado: (2020)

Allergen Challenge Chamber: an innovative solution in allergic rhinitis diagnosis
por: Krzych-Fałta, Edyta, et al.
Publicado: (2015)

Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement
por: Mandell, Kenneth J., et al.
Publicado: (2020)

Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018)

Allergen Avoidance in Allergic Asthma
por: Cipriani, Francesca, et al.
Publicado: (2017)

Multiple Allergen Simultaneous Test-Immunoblot Assay for Immunoglobulin E Detection in Patients with Isolated Allergic Conjunctivitis
por: Han, Jung Yeob, et al.
Publicado: (2021)

The holo beta‐lactoglobulin lozenge reduces symptoms in cat allergy—Evaluation in an allergen exposure chamber and by titrated nasal allergen challenge
por: Bergmann, Karl‐Christian, et al.
Publicado: (2023)

Intralymphatic Immunotherapy Alleviates Allergic Symptoms During Allergen Exposure in Daily Life
por: Lee, Sang Pyo, et al.
Publicado: (2018)

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases
por: Zahirović, Abida, et al.
Publicado: (2018)

First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients
por: Bergmann, Karl-Christian, et al.
Publicado: (2020)

Validated allergen exposure chamber is plausible tool for the assessment of house dust mite‐triggered allergic rhinitis
por: Zemelka‐Wiacek, Magdalena, et al.
Publicado: (2022)

Cat allergen exposure in a naturalistic exposure chamber: A prospective observational study in cat‐allergic subjects
por: Yang, William H., et al.
Publicado: (2022)

Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020)

Allergic asthma: An indication for allergen immunotherapy
por: Ankermann, Tobias, et al.
Publicado: (2023)

The Relationship of Parasite Allergens to Allergic Diseases
por: Caraballo, Luis, et al.
Publicado: (2023)

The most common cow’s milk allergenic proteins regarding to allergic symptoms
por: Shoormasti, Raheleh Shokouhi, et al.
Publicado: (2011)

Comparison of allergens and symptoms in patients with allergic rhinitis between 1990s and 2010s
por: Kim, Ji Heui, et al.
Publicado: (2020)

Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube(®): a randomized clinical trial
por: Gomes, Paul J, et al.
Publicado: (2019)

The first reptilian allergen and major allergen for fish‐allergic patients: Crocodile β‐parvalbumin
por: Ruethers, Thimo, et al.
Publicado: (2022)

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model
por: Torkildsen, Gail, et al.
Publicado: (2015)

Remote Allergen Exposure Elicits Eosinophil Infiltration into Allergen Non-Exposed Mucosal Organs and Primes for Allergic Inflammation
por: Olbrich, Courtney L., et al.
Publicado: (2020)

Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season
por: Gherasim, Alina, et al.
Publicado: (2023)

Variability of Offending Allergens of Allergic Rhinitis According to Age: Optimization of Skin Prick Test Allergens
por: Lee, Ji-Eun, et al.
Publicado: (2014)

Aqueous-Deficient Dry Eye Exacerbates Signs and Symptoms of Allergic Conjunctivitis in Mice
por: Kishimoto, Tatsuma, et al.
Publicado: (2022)

Poor understanding of allergen labelling by allergic and non‐allergic consumers
por: Holleman, Bregje C., et al.
Publicado: (2021)

Allergen immunotherapy and allergic rhinitis: false beliefs
por: Calderón, Moisés A, et al.
Publicado: (2013)

Induction of Allergic Responses to Peanut Allergen in Sheep
por: Van Gramberg, Jenna L., et al.
Publicado: (2012)

Allergen-specific immunotherapy in pediatric allergic asthma
por: Yukselen, Ayfer
Publicado: (2016)

Editorial: Allergens and Allergic Sensitization in Asia and the Tropics
por: Caraballo, Luis
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_64om185a74raej6eoslnu7d7s2